BSECompany Update4d ago · 7 Aug 2026, 01:28 pm
Notice published by way of an advertisement in respect of 22nd Annual General Meeting (AGM) of the Company.
Goldline Pharmaceutical Ltd · 544759
✦ AI SummaryResults
Goldline Pharmaceutical Ltd has published a notice in newspapers for its 22nd Annual General Meeting (AGM) and e-voting, as per SEBI regulations.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Goldline Pharmaceutical Ltd - 544759 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Attachments (1)
📄pdf
Download →
f3df7bec-8363-44ab-8962-486a61acb66b.pdf
View document text
The Manager
Corporate Relationship Department,
BSE Limited,
Phiroze Jeejeebhoy Towers, Dalal Street, Fort,
Mumbai - 400001.
Scrip Code: 544759, Scrip ID: GLPL,
Sub: Notice published by way of an advertisement in respect of 22nd Annual General Meeting
(AGM) of the Company.
Ref: Regulation 44 and 47 read with Regulation 30 of SEBI (Listing Obligation and Disclosure
Requirements) Regulations, 2015
Sir / Ma’am,
Pursuant to regulation 44 and 47 read with regulation 30 of SEBI (Listing Obligation and
Disclosure Requirements) Regulations, 2015, we are enclosing herewith the copies of newspaper
advertisements published in “Mahasagar” (Marathi Edition) and the “Financial Express”
(English Edition) on Friday, 07th August, 2026 informing about 22nd Annual General Meeting of the
Company and e-voting.
For your information and record.
Kindly acknowledge and oblige.
Thanking you,
Yours faithfully,
For Goldline Pharmaceutical Limited
Ruchi Sanket Modi
Company Secretary cum Compliance Officer
Date: 07th August, 2026